🇺🇸

US SEC Filing Intelligence

· daily

US SEC Filings Daily Market Digest — July 14, 2026

Today's 50 filings paint a picture of a bifurcated market: large-cap banks (JPMorgan, Wells Fargo) delivered strong YoY revenue growth (27% and 9% respectively) but face net interest margin compression, while small-cap names like OFA Group and BlueOne Card show widening losses and cash burn. Semiconductor capacity expansion is a clear theme, led by Tower Semiconductor's $3B Japan investment and SemiLEDs' equipment-driven revenue spike. Insider selling at Sea Ltd (COO sold $1M, CCO sold $59K) contrasts with no insider buying elsewhere. Corporate governance changes at Gamehaus and Mint Inc concentrate voting power, and clinical-stage companies (Alto Neuroscience, IGC Pharma) continue to raise capital. The energy sector shows mixed signals with BP guiding lower upstream production and Equinor executing buybacks. The most critical developments include CleanSpark's 20-year data center lease, AstraZeneca's $600M upfront license deal, and Pacific Airport's traffic decline and guidance cut. Overall, investors should favor large-cap financials with pricing power, monitor semiconductor supply chain plays, and avoid cash-burning micro-caps without clear catalysts.

18 high priority 32 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — July 14, 2026

The four filings within the S&P 500 Consumer Discretionary stream are dominated by AutoZone, which executed a significant debt capital raise, while Ulta Beauty made a strategic C-suite hire. The period-over-period comparisons, forward-looking statements, and insider trading data are notably absent from all filings, limiting trend analysis. AutoZone's $850 million senior notes issuance at a fixed 4.950% coupon signals a proactive refinancing or growth capital move, locking in favorable long-term rates amid a stable credit profile. Insider activity at AutoZone shows a minor gift by an SVP and a stock option grant to another executive, indicating routine compensation rather than conviction trading. Ulta Beauty's appointment of a new CTO from Domino's Pizza, with deep e-commerce and digital innovation expertise, aligns with its multi-channel expansion strategy. The lack of financial metrics, guidance, or comparative data across filings prevents portfolio-level trend synthesis, but the capital markets activity and executive hire provide actionable signals for debt investors and those tracking digital transformation in retail.

4 high priority 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 14, 2026

The 10 filings for the S&P 500 Healthcare stream on July 14, 2026, present a bifurcated picture. The dominant theme is a significant, coordinated insider compensation event at Zoetis Inc., where nine top executives were awarded phantom stock units on the same date, signaling a strong, unified retention and alignment strategy by the board. This is a clear positive signal for management stability and long-term focus. In contrast, Baxter International Inc. filed an 8-K detailing a non-cash restructuring of its reportable segments, a neutral operational move that simplifies its structure but offers no immediate financial catalyst. No period-over-period financial trends, forward-looking guidance, or capital allocation changes were disclosed in any of these filings, limiting the breadth of quantitative trend analysis. The key actionable insight is the collective insider activity at Zoetis, which, when combined with the lack of any bearish signals from other filings, suggests a cautiously optimistic outlook for the healthcare sector within this specific cohort.

9 high priority 1 medium 10 total filings
· daily

US Earnings Financial Results SEC Filings — July 14, 2026

This digest of 36 filings reveals a market bifurcated between a handful of growth stories and a broad swath of micro-cap companies in severe financial distress. Revenue growth is highly concentrated, with only a few companies like Kestra Medical Technologies (+59% YoY) and AngioDynamics (+9.5% YoY) showing robust top-line expansion, while many others, including Americas CarMart (-10.3% YoY) and SemiLEDs (-57.3% YoY), experienced sharp revenue declines. A dominant theme is the widening of net losses across the portfolio, with 13 out of 36 companies reporting a deterioration in profitability, often driven by surging operating expenses, interest costs, or non-cash charges like impairments and derivative losses. Capital allocation is overwhelmingly focused on survival, with numerous companies relying on related-party debt, dilutive equity issuances, or convertible notes to fund operations, and insider activity is notably absent from the filings, suggesting a lack of management conviction. The most critical development is the high number of going-concern warnings and default situations, particularly in the energy and technology sectors, which poses significant risk for investors. The market implications are clear: a flight to quality is warranted, favoring companies with positive operating cash flow and sustainable growth, while avoiding the deep-value traps in the micro-cap space.

36 high priority 36 total filings
· daily

US Executive Compensation Proxy SEC Filings — July 14, 2026

The three proxy filings reveal a stark contrast in corporate governance and shareholder risk. GRAHAM CORP and Powerlaw Corp. present routine, low-materiality annual meetings with standard director elections and neutral sentiment, indicating stable, predictable governance. In sharp contrast, Creative Medical Technology Holdings (CELZ) presents a high-stakes special meeting with two proposals that would massively dilute existing shareholders—authorized shares increasing 4x and full exercise of deeply discounted warrants. The period-over-period data shows CELZ has only 4.7M shares outstanding but 10.6M shares already committed via warrants/options, creating an overhang of 224% of current float. The insider activity data reveals no insider buying to offset the dilution risk, while the forward-looking data indicates the company seeks flexibility for capital raising with no specific commitments, suggesting potential cash burn concerns. The portfolio-level pattern is a governance divergence: established industrial/tech firms maintain status quo, while a micro-cap biotech pursues aggressive capital structure changes that could destroy shareholder value.

3 high priority 3 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 14, 2026

The sole filing in this IPO Pipeline digest is from Attovia Therapeutics, a pre-revenue biopharmaceutical company seeking to go public on Nasdaq. The company has no approved products, no revenue, and significant accumulated losses, but holds a strong cash position of $132.6 million to fund its pipeline. The mixed sentiment reflects the high-risk, high-reward profile typical of early-stage biotech IPOs. With no period-over-period comparisons, insider activity, or forward guidance available, the intelligence is limited to the company's financial health and clinical-stage risks. The IPO represents a pure speculative opportunity for investors willing to bet on its lead candidates ATTO-1310 and ATTO-2306.

1 high priority 1 total filings
· daily

US SEC Trading Suspension Halt Orders — July 14, 2026

On July 14, 2026, two US-listed companies announced voluntary transfers of their stock listings between major exchanges, signaling a trend of proactive exchange migration rather than forced delistings. D-Wave Quantum Inc. (QBTS) is moving from the NYSE to Nasdaq, while Trinity Capital Inc. (TRIN) is transferring from Nasdaq to the NYSE and NYSE Texas. Both transfers are voluntary, approved by their boards, and involve no change in ticker symbols for the common stock, though Trinity's notes will see ticker adjustments. The moves are scheduled to take effect around July 27, 2026, with seamless trading continuity. No financial metrics, insider activity, or forward-looking guidance were disclosed in these filings, limiting the depth of quantitative trend analysis. The key takeaway is that both companies are seeking exchange environments they perceive as more advantageous, potentially for visibility, liquidity, or regulatory alignment, without any distress signals.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — July 14, 2026

The July 14, 2026, executive and director change filings reveal a market in transition, with a notable wave of CFO and C-suite departures across sectors, including Pentair, Fortrea, and Laird Superfood, often tied to personal opportunities or retirement. A strong counter-trend of strategic appointments is visible, particularly in tech and consumer goods, where companies like PagerDuty, Domino's Pizza, and Ulta Beauty are adding seasoned leaders with deep enterprise and digital expertise. The most critical development is Pentair's sharp guidance revision (-19% at the midpoint) due to Pool channel destocking, a significant red flag for the pool and broader housing-related sectors. Insider activity is mixed but leans positive, with AMREP Corp. awarding substantial retention bonuses to its CEO and CFO, while the GPB entities remain in a distressed wind-down. The data suggests a bifurcated market: companies with strong fundamentals are upgrading leadership for growth, while others face execution risks and talent flight.

33 high priority 33 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 14, 2026

The July 14, 2026, batch of 33 filings reveals a pronounced wave of C-suite and board-level transitions across US-listed companies, with a notable skew toward CFO changes (8 filings) and board refreshment (14 filings). A key period-over-period trend is the contrast between companies executing planned, strategic leadership upgrades (e.g., PVH Corp, Allstate, PagerDuty) and those undergoing forced departures amid financial distress or restructuring (e.g., Pentair, GPB Automotive, Coronado Global). Insider activity is mixed: while no outright insider selling is flagged, the departure of CFOs at Pentair and Laird Superfood, and the resignation of a director at a receivership-bound entity, signal caution. Forward-looking statements are sparse but critical, with Pentair's sharp guidance revision (-18% at the midpoint) being the most material catalyst. Capital allocation actions are limited to AMREP's executive bonuses and Longeveron's accelerated CEO vesting, suggesting a focus on retention rather than shareholder returns. The most critical development is the Pentair CFO departure coupled with a severe guidance cut, which has immediate negative implications for the Pool sector and related industrials. Overall, the digest points to a market where leadership changes are a key signal of either strategic renewal or underlying operational weakness, demanding careful differentiation.

33 high priority 33 total filings
· daily

USA Insider Trading Pulse — July 14, 2026

The July 14, 2026, insider trading pulse reveals a market dominated by routine compensation-driven transactions (awards, option exercises, tax-withholding sales) rather than conviction-based buying or selling, with 84% of filings carrying neutral sentiment. The most actionable signals cluster around three areas: (1) a coordinated insider selling pattern at Barnes & Noble Education, where the CEO received a large stock award while three other executives sold shares at $11.61, suggesting potential divergence in management outlook; (2) a significant open-market sale by Sea Ltd's COO ($1.02M via a 10b5-1 plan) amid nine total transactions, signaling pre-planned portfolio diversification; and (3) a massive director acquisition at Gogoro Inc. (9.56M shares) that warrants investigation into the catalyst. Period-over-period comparisons from the enriched data were limited in these filings, but the concentration of insider awards at BOK Financial (12 directors receiving identical grants) and Lattice Semiconductor (6 executives with tax-withholding sales) highlights routine equity compensation cycles. The key portfolio-level pattern is the absence of bullish conviction buying, with only two small purchases by Horizon Kinetics Asset Management across RENN Fund and Texas Pacific Land Corp. The most critical development is the Celsius Holdings insider dispositions ($6.94M each by three insiders), which, while labeled neutral, represent a material cash-out event that bears watching for follow-on sales.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — July 14, 2026

This digest covers 11 SEC filings related to US M&A and takeover activity, with a heavy concentration on SPAC lifecycle events (IPOs, unit separations, deadline extensions) and a smaller set of completed acquisitions. The most material developments are the closing of three significant take-private deals: Apollo's acquisition of Emerald Holding and Questex, Ares Management's $1.7 billion buyout of Whitestone REIT, and Ligand Pharmaceuticals' $739 million acquisition of XOMA Royalty. These transactions signal continued private equity appetite for public companies in the B2B events, retail real estate, and biotech royalty sectors. The SPAC filings, while routine, reveal a sector still struggling to consummate deals, with one SPAC (Oak Woods) extending its deadline by 18 months, indicating persistent challenges in finding viable targets. The completed acquisitions of flyExclusive's aviation assets and Catalyst Bancorp's purchase of Lakeside Bancshares highlight ongoing consolidation in the private aviation and regional banking sectors. Overall, the period shows a bifurcated market: robust M&A activity for established operating companies, contrasted with a sluggish SPAC market where many vehicles are burning through extension periods without announced targets.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 14, 2026

Overnight SEC filings from July 13-14, 2026 reveal a market bifurcated between strategic industrial expansion and consumer/tech headwinds. Tower Semiconductor's $3B Japan capacity expansion and CleanSpark's 175 MW data center lease signal major infrastructure plays, while SemiLEDs' revenue surge from buy-sell orders and OFA Group's 255% revenue growth mask underlying operational fragility. Insider selling at Sea Ltd ($1.02M by COO) and RH ($412K by director) contrasts with director accumulation at Gogoro (9.56M shares). Period-over-period trends show margin compression at Destiny Media (-170 bps gross margin) and Unity Bancorp (-12.2% YoY net income), while BP's guidance warns of lower production and a $1B charge. The most critical developments are Tower's 2028 revenue target of $3.6B, CleanSpark's AI infrastructure catalyst, and Coronado Global's CEO change amid profitability struggles.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 13, 2026

The six filings for the S&P 500 Technology sector on July 13, 2026, reveal a pronounced insider selling pattern among high-profile cybersecurity and networking executives, with CEOs at CrowdStrike and Arista Networks, and a director at Datadog, collectively liquidating over $24 million in stock, all under Rule 10b5-1 plans, which may signal pre-planned diversification but also raises caution on valuation. Cisco's 13F shows a concentrated portfolio with a $105.9 million stake in CoreWeave, indicating a strategic bet on AI infrastructure, while its EVP's tax-related stock withholding is a routine non-signal. Autodesk's establishment of a $2.0 billion commercial paper program to finance its MaintainX acquisition reflects a leveraged growth strategy in the software space. Period-over-period data was not available in these filings, limiting trend analysis, but the insider activity pattern suggests management is taking profits at current levels. The sector appears to be in a capital-intensive phase, with Autodesk pursuing M&A and Cisco allocating capital to AI-focused investments, while insiders at high-growth names are reducing exposure.

4 high priority 2 medium 6 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 13, 2026

The four filings from NASDAQ-100 constituents reveal a mixed picture: insider activity at Intuitive Surgical and Cisco shows routine tax-related stock movements rather than conviction signals, while Strategy Inc. continues its aggressive capital markets activity, selling $466.7M in equity via its ATM program but pausing bitcoin purchases for the week. Cisco's 13F filing discloses a concentrated portfolio heavily weighted toward broad-market ETFs and a notable $105.9M stake in CoreWeave, signaling a strategic bet on AI infrastructure. No period-over-period comparisons or forward-looking guidance were provided in any filing, limiting trend analysis. The key takeaway is that capital allocation patterns diverge sharply—Strategy Inc. is aggressively funding its bitcoin treasury via equity issuance, while Cisco and Intuitive Surgical show no buyback or dividend activity in these filings. The absence of insider buying or selling for conviction purposes suggests management teams are in a 'steady state' mode, with no urgent signals to act upon.

2 high priority 2 medium 4 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 13, 2026

The July 13, 2026, batch of 29 filings reveals a mixed landscape for activist and institutional activity, with a notable tilt toward passive position disclosures and a few high-conviction activist engagements. The most critical development is **Fresenius Medical Care's** planned exit from **Humacyte** via a 10b5-1 plan to sell up to 6.8% of the company, a strong bearish signal for the biotech. Conversely, **Xerox Holdings** saw activist **STARTEEPO Invest** increase its stake to 6.84% and signal a more active engagement on strategy, while **IRIDEX Corp** remains under the influence of a 29.92% holder with a 12% interest note. The data shows a clear pattern of passive institutional investors (Millennium, D.E. Shaw, Wasatch) making routine 13G filings, indicating a wait-and-see approach. A key period-over-period trend is the complete exit of **Jericho Capital** from **Upstart Holdings** and the reduction of **Impactive Capital** below 5% in **Asbury Automotive**, suggesting a loss of conviction in those names. Overall, the digest points to selective activist pressure in value/industrial plays and a cautious, passive posture from large asset managers, with the Humacyte sell-down being the most actionable bearish event.

7 high priority 22 medium 29 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 13, 2026

The sole filing in this period, from Capital One Multi-Asset Execution Trust, is a routine 8-K announcing the issuance of two classes of asset-backed notes (Class A 2026-1 and 2026-2) on July 16, 2026. The filing contains no financial performance data, period-over-period comparisons, insider activity, or forward-looking guidance, resulting in a neutral sentiment and low materiality score of 3/10. This is a standard operational update for a structured finance vehicle, offering no actionable investment signals for the broader S&P 500 Financials sector. The absence of any substantive financial or strategic data from the only filing in scope limits the ability to identify sector-wide trends or generate alpha-generating insights. Investors should view this as a non-event for portfolio positioning, with no implications for the financial sector's earnings trajectory or risk profile.

1 medium 1 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 13, 2026

The three filings in the S&P 500 Energy stream for July 13, 2026, present a mixed picture of insider sentiment and strategic capital deployment. A notable insider purchase by a 10% owner at Texas Pacific Land Corp, though small in size, signals long-term conviction in the company's value at current levels. Conversely, a large, pre-planned sale by the CFO of Phillips 66, following a stock option exercise, introduces a bearish signal for that specific name, though the use of a 10b5-1 plan tempers the alarm. The most significant strategic development comes from Williams Companies, which announced a joint venture financing for behind-the-meter Power Innovation projects, a clear pivot towards the growing data center and electrification demand theme. The lack of specific financial guidance in the Williams filing creates uncertainty, but the strategic direction is a positive catalyst for the sector. Overall, the day's filings highlight a divergence between capital returns to executives and strategic reinvestment in energy transition infrastructure.

2 high priority 1 medium 3 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 13, 2026

All five filings today are from Union Pacific Corp (UNP), a core S&P 500 Industrials railroad company, and exclusively report routine insider stock awards to senior executives. There are no period-over-period comparisons, forward-looking guidance, capital allocation changes, or transaction details in the enriched data, limiting the depth of trend analysis. The awards are small in value (ranging from ~$635 to ~$2.4K) and represent standard compensation grants, not open-market purchases or sales, indicating neutral management sentiment with no actionable conviction signals. The aggregate insider holdings post-transaction (e.g., CFO holds 114,667 shares) suggest significant alignment with shareholders, but the lack of any material financial or operational disclosures means the overall portfolio-level signal is muted. The key takeaway is a stable, routine insider activity pattern with no red flags or catalysts, reinforcing a steady-state view for Union Pacific in the near term.

5 high priority 5 total filings
· daily

US Material Events SEC 8-K Filings — July 13, 2026

The July 13, 2026, filings reveal a market sharply bifurcated between aggressive capital deployment and acute financial distress. Major capital markets events dominate, with **Public Storage** raising $900M in senior notes to fund a transformative acquisition and **Talos Energy** issuing $800M in high-yield notes for a Gulf of America acquisition, while **Realty Income** expanded its credit facilities to $5.5B. The biotech sector saw a landmark transaction as **Edgewise Therapeutics** sold its muscular dystrophy business for up to $2.65B, and **Agenus** secured $340M for a pivotal Phase 3 trial. Conversely, several companies are in dire straits: **MSP Recovery** received a $250K emergency advance amid ongoing financial distress, **Splash Beverage** settled $2.8M in debt for a mere $302K, and **Silo Pharma** is raising $11.7M via a dilutive private placement. A wave of insider activity is notable, with multiple CFO and CRO departures, including **CoStar Group** appointing a new CFO who delivered a 25% cost reduction, and **Shutterstock** seeing its CEO step down immediately. The overall sentiment is mixed, with large-scale strategic moves and liquidity events contrasting with numerous small-cap distress signals and leadership transitions.

50 high priority 50 total filings
· daily

Insider Trading Pulse — July 13, 2026

Today's insider trading digest reveals a clear bifurcation: aggressive insider buying by CEOs and directors at several small/mid-cap companies, contrasted with massive insider selling at large-cap growth names. The most significant buying signals come from Dreamland Ltd (CEO $2.45M purchase) and 51Talk Online Education Group (CEO $9.3M in 10b5-1 purchases), while the largest sales are at UNITED MICROELECTRONICS (CFO $294M sale) and SharkNinja (Director $401M sale). A notable cluster of option exercises and tax-withholding sales at Calumet, Esperion Therapeutics, and Octave Specialty Group suggests these are routine compensation events rather than conviction-based trades. The Esperion Therapeutics filings show a coordinated disposition of shares and options by the entire C-suite and board, likely tied to a corporate event. Period-over-period comparisons were not available in the enriched data for most filings, limiting trend analysis, but the sheer volume and direction of insider activity provide actionable signals.

50 high priority 50 total filings